Increased cathelicidin LL-37 colonic expression is associated with tumor progression in colorectal cancer.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Increased cathelicidin LL-37 colonic expression is associated with tumor progression in colorectal cancer.
- Published In:
- Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 76(6), 707-715 (2025)
- Authors:
- Wlodarczyk, J, Dziki, L, Fichna, J
- Database ID:
- RPEP-14166
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14166APA
Wlodarczyk, J; Dziki, L; Fichna, J. (2025). Increased cathelicidin LL-37 colonic expression is associated with tumor progression in colorectal cancer.. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 76(6), 707-715. https://doi.org/10.26402/jpp.2025.6.08
MLA
Wlodarczyk, J, et al. "Increased cathelicidin LL-37 colonic expression is associated with tumor progression in colorectal cancer.." Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2025. https://doi.org/10.26402/jpp.2025.6.08
RethinkPeptides
RethinkPeptides Research Database. "Increased cathelicidin LL-37 colonic expression is associate..." RPEP-14166. Retrieved from https://rethinkpeptides.com/research/wlodarczyk-2025-increased-cathelicidin-ll37-colonic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.